Moxie Dwight
Insider CIK 1803375 · RVNC SVP, GC & Secretary
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RVNC Revance Therapeutics, Inc. | D To issuer | 2025-02-06 | 2025-02-06 | 95,979 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2025-02-06 | 2025-02-06 | 18,125 | — | $0 | 18,125 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | D To issuer | 2025-02-06 | 2025-02-06 | 18,125 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | U Tender | 2025-02-04 | 2025-02-06 | 47,815 | $3.65 | $174.5K | 95,979 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2025-02-03 | 2025-02-05 | 5,979 | — | $0 | 143,794 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2024-03-18 | 2024-03-19 | 8,125 | $5.04 | $41.0K | 137,815 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2024-03-15 | 2024-03-19 | 3,269 | $5.31 | $17.4K | 145,940 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2024-02-29 | 2024-03-04 | 15,143 | — | $0 | 149,209 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2024-01-31 | 2024-02-02 | 135,000 | — | $0 | 135,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2024-01-31 | 2024-02-02 | 90,000 | — | $0 | 134,066 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2023-09-06 | 2023-09-07 | 11,000 | $17.06 | $187.7K | 44,066 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2023-09-05 | 2023-09-07 | 23,853 | $17.81 | $424.8K | 55,066 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2023-08-11 | 2023-08-15 | 19,346 | — | $0 | 88,511 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2023-08-11 | 2023-08-15 | 9,592 | $18.91 | $181.4K | 78,919 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2023-05-15 | 2023-05-16 | 21,401 | $34.55 | $739.4K | 69,165 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2023-03-15 | 2023-03-17 | 7,330 | $30.65 | $224.7K | 48,217 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2023-03-09 | 2023-03-09 | 18,496 | $31.59 | $584.3K | 55,547 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2023-01-31 | 2023-02-02 | 43,774 | — | $0 | 43,774 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2022-09-22 | 2023-03-09 | 42,349 | — | $0 | 74,043 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2022-09-14 | 2022-09-16 | 11,000 | $27.07 | $297.8K | 31,694 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2022-03-15 | 2022-03-17 | 2,229 | $15.79 | $35.2K | 42,694 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2022-03-15 | 2022-03-17 | 2,881 | $15.79 | $45.5K | 44,923 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2022-02-02 | 2023-05-16 | 42,349 | — | $0 | 90,566 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2022-02-02 | 2022-02-04 | 68,093 | — | $0 | 68,093 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2021-09-27 | 2021-09-28 | 1,675 | $30.00 | $50.3K | 47,804 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2021-03-15 | 2021-03-17 | 2,881 | $27.73 | $79.9K | 49,479 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2021-02-02 | 2021-02-04 | 35,002 | — | $0 | 35,002 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2021-02-02 | 2021-02-04 | 19,346 | — | $0 | 52,360 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2020-09-30 | 2020-10-02 | 4,236 | $25.14 | $106.5K | 33,014 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2020-09-30 | 2020-10-02 | 12,250 | — | $0 | 37,250 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2020-02-18 | 2020-02-19 | 170,000 | — | $0 | 170,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2020-02-18 | 2020-02-19 | 25,000 | — | $0 | 25,000 | SEC↗ |